Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (Q42544449)
Jump to navigation
Jump to search
scientific article published on 26 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study |
scientific article published on 26 January 2016 |
Statements
1 reference
Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study (English)
1 reference
Takashi Iizuka
1 reference
Kotaro Iemitsu
1 reference
Masahiro Takihata
1 reference
Masahiko Takai
1 reference
Shigeru Nakajima
1 reference
Nobuaki Minami
1 reference
Shinichi Umezawa
1 reference
Akira Kanamori
1 reference
Hiroshi Takeda
1 reference
Takehiro Kawata
1 reference
Shogo Ito
1 reference
Taisuke Kikuchi
1 reference
Hikaru Amemiya
1 reference
Mizuki Kaneshiro
1 reference
Atsuko Mokubo
1 reference
Tetsuo Takuma
1 reference
Hideo Machimura
1 reference
Keiji Tanaka
1 reference
Taro Asakura
1 reference
Akira Kubota
1 reference
Sachio Aoyagi
1 reference
Kazuhiko Hoshino
1 reference
Masashi Ishikawa
1 reference
Yoko Matsuzawa
1 reference
Mitsuo Obana
1 reference
Nobuo Sasai
1 reference
Hideaki Kaneshige
1 reference
Fuyuki Minagawa
1 reference
Tatsuya Saito
1 reference
Kazuaki Shinoda
1 reference
Masaaki Miyakawa
1 reference
Yasushi Tanaka
1 reference
Yasuo Terauchi
1 reference
Ikuro Matsuba
1 reference
26 January 2016
1 reference
1 reference
267
1 reference
Identifiers
1 reference
1 reference
1 reference